Genetic background of left ventricular hypertrophy in Uzbek hypertensive men

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 7, 2010, Pages 466-472

  Kurbanova, Dilorom ^a   Eliseyeva, Marietta ^a  

^a Republican Specialized Center of Cardiology ^*  (Uzbekistan)

Author keywords

Hypertension genetics; Hypertrophy, left ventricular epidemiology; Polymorphism, genetic; Uzbekistan epidemiology

Indexed keywords

AGT PROTEIN; ALDOSTERONE SYNTHASE; AT1R PROTEIN; GENOMIC DNA; INHIBITOR OF DIFFERENTIATION PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; ESSENTIAL HYPERTENSION; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALDOSTERONE SYNTHASE; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PREVALENCE; RECEPTOR, ANGIOTENSIN, TYPE 1; UZBEKISTAN;

EID: 79959995567     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23. (Pubitemid 40138015)
2. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-41. (Pubitemid 32200259)
3. Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000;140:848-56.
4. Morise T, Takeuchi Y, Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 1994;343:125. (Pubitemid 24019379)
5. Chiang FT, Lai ZP, Chern TH, Tseng CD, Hsu KL, Lo HM, et al. Lack of association of the angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population. Am J Hypertens 1997;10:197-201.
6. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, et al. Molecular variant M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997;15:607-11.
7. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995;25:688-93.
8. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995;13:1602-9. (Pubitemid 26015783)
9. Zhang X, Erdmann J, Regitz-Zagrosek V, Kürzinger S, Hense HW, Schunkert H. Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene. J Hypertens 2000;18:267-72. (Pubitemid 30142842)
10. Takahashi N, Smithies O. Human genetics, animal models and computer simulations for studying hypertension. Trends Genet 2004;20:136-45. (Pubitemid 38230028)
11. Devereux RB, Pini R, Aurigemma GP, Roman MJ. Measurement of left ventricular mass: methodology and expertise. J Hypertens 1997;15:801-9. (Pubitemid 27344842)
12. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976;37:7-11.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. (Pubitemid 9091990)
14. Russ AP, Maerz W, Ruzicka V, Stein U, Gross W. Rapid detection of the hypertension-associated Met235 - >Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993;2:609-10. (Pubitemid 23140035)
15. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998;97:569-75. (Pubitemid 28090686)
16. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994;24:63-9. (Pubitemid 24195405)
17. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-3. (Pubitemid 24295876)
18. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
19. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94:708-12. (Pubitemid 26289226)
20. Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarez V, et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998;40:375-9. (Pubitemid 28506048)
21. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993;44:292-7.
22. Berge KE, Berg K. No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994;45:169-74.
23. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992;1:72-5.
24. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, et al. Evidence for association and genetic linkage of the angiotensin- converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998;97:1766-72.
25. O'Donnell CJ, Lindpainther K, Larson MG. The ACE deletion insertion polymorphism and hypertension: an association analysis in the Framingham Heart Study. In: 46th Annual Scientific Session of the American College of Cardiology; March 16-19, 1997; Anaheim, CA. p. 724-32.
26. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994;90:2622-8.
27. Kimura M, Yokota M, Fujimura T, Kato S, Hirayama H, Tsunekawa A, et al. Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects. Cardiology 1997;88:309-14. (Pubitemid 27219963)
28. Ueno H, Takata M, Yasumoto K, Tomita S, Inoue H. Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy. Jpn Heart J 1999;40:589-98.
29. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
30. Rasmussen-Torvik LJ, North KE, Gu CC, Lewis CE, Wilk JB, Chakravarti A, et al. A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes. Hypertension 2005;46:1294-9. (Pubitemid 43189726)
31. Kuznetsova T, Staessen JA, Thijs L, Kunath C, Olszanecka A, Ryabikov A, et al. Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 2004;110:2644-50. (Pubitemid 39453014)
32. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, et al. Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension 1996;28:1076-80.
33. Kikuya M, Sugimoto K, Katsuya T, Suzuki M, Sato T, Funahashi J, et al. A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study. Hypertens Res 2003;26:141-5. (Pubitemid 36372332)
34. Stella P, Bigatti G, Tizzoni L, Barlassina C, Lanzani C, Bianchi G, et al. Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. J Am Coll Cardiol 2004;43:265-70. (Pubitemid 38201154)